USTEKINUMAB-TTWE

NDC 82009-160 · Quallent Pharmaceuticals Health LLC

Generic nameustekinumab-ttwe

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)USTEKINUMAB

Strength45 mg/.5mL

Pharmacologic classInterleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]

Marketing categoryBLA

Packages

82009-160-11 — 1 SYRINGE in 1 CARTON (82009-160-11) / .5 mL in 1 SYRINGE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65219-822 — ustekinumab-aauz, 65219-824 — ustekinumab-aauz, 65219-826 — ustekinumab-aauz, 65219-828 — ustekinumab-aauz, 65219-862 — ustekinumab-aauz, 65219-866 — ustekinumab-aauz, 72606-027 — ustekinumab-stba, 72606-028 — ustekinumab-stba, 72606-029 — ustekinumab-stba, 72606-060 — ustekinumab-stba, 82009-161 — ustekinumab-ttwe, 82009-162 — ustekinumab-ttwe, 82009-163 — ustekinumab-ttwe, 83257-023 — ustekinumab, 83257-024 — ustekinumab, 83257-025 — ustekinumab, 83257-026 — ustekinumab, 83457-651 — ustekinumab-ttwe, 83457-652 — ustekinumab-ttwe, 84612-055 — ustekinumab-auub, +20 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.